Tacrolimus ointment
پماد تاکرولیموس
🧴 DermatologicalsTopical calcineurin inhibitor
Market / country: 🇺🇸 USA
Protopic (US)
🧮 Dose calculator
Atopic dermatitis (eczema) · Regimen source: FDA Tacrolimus oint. · Dosage and Administration — Adult
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to tacrolimus. FDA Tacrolimus oint. · Contraindications
- ⛔ Not indicated for children under 2. FDA Tacrolimus oint. · Indications and Usage
Warnings
- • Boxed warning: rare reports of malignancy (skin and lymphoma); avoid long-term continuous use; second-line only. FDA Tacrolimus oint. · Boxed Warning
Formulations
- 0.03% ointment — ointment 🇺🇸 USA FDA Tacrolimus oint. · How Supplied
- 0.1% ointment — ointment 🇺🇸 USA FDA Tacrolimus oint. · How Supplied
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Tacrolimus oint. · Pregnancy
- 🤱 BreastfeedingDangerous / avoid
Label: breastfeeding not recommended, or choose between the drug and breastfeeding. FDA Tacrolimus oint. · Nursing Mothers
“Because of the potential for serious adverse reactions in nursing infants from tacrolimus, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Tacrolimus oint. · Pediatric Use
“Since the safety and efficacy of tacrolimus ointment have not been established in pediatric patients below 2 years of age, its use in this age group is not recommended.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Tacrolimus oint. · Geriatric Use
“Four hundred and four (404) patients ≥ 65 years old received tacrolimus ointment in phase 3 studies.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA210393
- DailyMed (FDA label)FDA Tacrolimus oint.
- MedlinePlus (NIH)Tacrolimus Topical
- WHO ATC/DDDD11AH01
- Darooyab (Iran)Tacrolimus
🇮🇷 Registered in Iran Darooyab · G-2744/Tacrolimus
Dosage forms with Iranian generic codes, per Darooyab.
- 18952 · TACROLIMUS 0.03% 10G OINT · پماد تاکرولیموس ۰٫۰۳ درصد ۱۰ گرم
- 11622 · TACROLIMUS 0.03% 30G OINT · پماد تاکرولیموس ۰٫۰۳ درصد ۳۰ گرم
- 08131 · TACROLIMUS 0.03% 60G OINT · پماد تاکرولیموس ۰٫۰۳ درصد ۶۰ گرم
- 08187 · TACROLIMUS 0.1% 10G OINT · پماد تاکرولیموس ۰٫۱ درصد ۱۰ گرم
- 06599 · TACROLIMUS 0.1% 30G OINT · پماد تاکرولیموس ۰٫۱ درصد ۳۰ گرم
- 05804 · TACROLIMUS 0.5MG CAP · کپسول تاکرولیموس ۰٫۵ میلیگرم
- 02083 · TACROLIMUS 1MG CAP · کپسول تاکرولیموس ۱ میلیگرم
- 02084 · TACROLIMUS 5MG CAP · کپسول تاکرولیموس ۵ میلیگرم
- 02087 · TACROLIMUS 5MG/ML FOR INFU · محلول انفوزیون تاکرولیموس ۵ میلیگرم / میلیلیتر
- 50539 · TACROLIMUS 3MG CAP · کپسول تاکرولیموس ۳ میلیگرم
- 52291 · TACROLIMUS CAPSULE, EXTENDED RELEASE ORAL 0.5 mg · کپسول آهستهرهش تاکرولیموس ۰٫۵ میلیگرم
- 52332 · TACROLIMUS CAPSULE, EXTENDED RELEASE ORAL 1 mg · کپسول آهستهرهش تاکرولیموس ۱ میلیگرم
- 52333 · TACROLIMUS CAPSULE, EXTENDED RELEASE ORAL 5 mg · کپسول آهستهرهش تاکرولیموس ۵ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Tacrolimus oint. · How SuppliedFDA Tacrolimus oint. · Dosage and Administration — AdultFDA Tacrolimus oint. · Dosage and Administration — PediatricFDA Tacrolimus oint. · ContraindicationsFDA Tacrolimus oint. · Indications and UsageFDA Tacrolimus oint. · Boxed WarningFDA Tacrolimus oint. · PregnancyFDA Tacrolimus oint. · Nursing MothersFDA Tacrolimus oint. · Pediatric UseFDA Tacrolimus oint. · Geriatric UseFDA Tacrolimus oint. · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-2744/Tacrolimus
- Clinical review⚠ Unverified